Cargando…
A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors
Bladder cancer (BC) is a leading cause of male cancer-related deaths globally. Immunotherapy is showing promise as a treatment option for BC. Numerous studies suggested that necroptosis and long noncoding RNAs (lncRNAs) were critical players in the development of cancers and interacting with cancer...
Autores principales: | Li, Han, Lv, Zhengtong, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578762/ https://www.ncbi.nlm.nih.gov/pubmed/37832111 http://dx.doi.org/10.1097/MD.0000000000035196 |
Ejemplares similares
-
A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer
por: Jin, Yuzhou, et al.
Publicado: (2023) -
lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis
por: Ding, Zhenshan, et al.
Publicado: (2021) -
Crosstalk between autophagy and bladder transitional cell carcinoma by autophagy-related lncRNAs
por: Feng, Jie, et al.
Publicado: (2023) -
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022) -
Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis
por: Wu, Yu-Peng, et al.
Publicado: (2016)